Ppe Net - CASI Pharmaceuticals Inc (NASDAQ:CASI) - Alpha Spread
C

CASI Pharmaceuticals Inc
NASDAQ:CASI

Watchlist Manager
CASI Pharmaceuticals Inc
NASDAQ:CASI
Watchlist
Price: 6.54 USD -3.25% Market Closed
Market Cap: 87.6m USD
Have any thoughts about
CASI Pharmaceuticals Inc?
Write Note

CASI Pharmaceuticals Inc
PP&E Net

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

CASI Pharmaceuticals Inc
PP&E Net Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive PP&E Net Analysis
Latest Figures & CAGR of Competitors

Company PP&E Net CAGR 3Y CAGR 5Y CAGR 10Y
C
CASI Pharmaceuticals Inc
NASDAQ:CASI
PP&E Net
$11.6m
CAGR 3-Years
3%
CAGR 5-Years
45%
CAGR 10-Years
61%
Abbvie Inc
NYSE:ABBV
PP&E Net
$5B
CAGR 3-Years
-1%
CAGR 5-Years
9%
CAGR 10-Years
8%
Gilead Sciences Inc
NASDAQ:GILD
PP&E Net
$5.3B
CAGR 3-Years
2%
CAGR 5-Years
2%
CAGR 10-Years
14%
Amgen Inc
NASDAQ:AMGN
PP&E Net
$6.1B
CAGR 3-Years
8%
CAGR 5-Years
3%
CAGR 10-Years
1%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
PP&E Net
$1.8B
CAGR 3-Years
10%
CAGR 5-Years
18%
CAGR 10-Years
9%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
PP&E Net
$4.3B
CAGR 3-Years
9%
CAGR 5-Years
10%
CAGR 10-Years
20%

See Also

What is CASI Pharmaceuticals Inc's PP&E Net?
PP&E Net
11.6m USD

Based on the financial report for Dec 31, 2023, CASI Pharmaceuticals Inc's PP&E Net amounts to 11.6m USD.

What is CASI Pharmaceuticals Inc's PP&E Net growth rate?
PP&E Net CAGR 10Y
61%

Over the last year, the PP&E Net growth was -12%. The average annual PP&E Net growth rates for CASI Pharmaceuticals Inc have been 3% over the past three years , 45% over the past five years , and 61% over the past ten years .

Back to Top